These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409 [TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
25. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Burger M Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704 [No Abstract] [Full Text] [Related]
26. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]
27. Lynch syndrome and urologic malignancies: a contemporary review. Lim A; Rao P; Matin SF Curr Opin Urol; 2019 Jul; 29(4):357-363. PubMed ID: 31045926 [TBL] [Abstract][Full Text] [Related]
28. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
29. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer. Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055 [TBL] [Abstract][Full Text] [Related]
30. Genetic testing for Lynch syndrome in the province of Ontario. Wang M; Aldubayan S; Connor AA; Wong B; Mcnamara K; Khan T; Semotiuk K; Khalouei S; Holter S; Aronson M; Cohen Z; Gallinger S; Charames G; Pollett A; Lerner-Ellis J Cancer; 2016 Jun; 122(11):1672-9. PubMed ID: 27019099 [TBL] [Abstract][Full Text] [Related]
31. Approach to Lynch Syndrome for the Gastroenterologist. Bui QM; Lin D; Ho W Dig Dis Sci; 2017 Feb; 62(2):299-304. PubMed ID: 27990589 [TBL] [Abstract][Full Text] [Related]
32. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
33. Identifying Lynch syndrome: we are all responsible. Sanchez JA; Vogel JD; Kalady MF; Bronner MP; Skacel M; Church JM Dis Colon Rectum; 2008 Dec; 51(12):1750-6. PubMed ID: 18682882 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical Screening of Upper Tract Urothelial Carcinomas for Lynch Syndrome Diagnostics: A Systematic Review. Rasmussen M; Madsen MG; Therkildsen C Urology; 2022 Jul; 165():44-53. PubMed ID: 35217028 [TBL] [Abstract][Full Text] [Related]
35. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Vilar E; Mork ME; Cuddy A; Borras E; Bannon SA; Taggart MW; Ying J; Broaddus RR; Luthra R; Rodriguez-Bigas MA; Lynch PM; You YQ Cancer Genet; 2014; 207(10-12):495-502. PubMed ID: 25432668 [TBL] [Abstract][Full Text] [Related]
36. Lynch syndrome and MYH-associated polyposis: review and testing strategy. Goodenberger M; Lindor NM J Clin Gastroenterol; 2011 Jul; 45(6):488-500. PubMed ID: 21325953 [TBL] [Abstract][Full Text] [Related]
37. Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer. Bruegl AS; Ring KL; Daniels M; Fellman BM; Urbauer DL; Broaddus RR Cancer Prev Res (Phila); 2017 Feb; 10(2):108-115. PubMed ID: 27965287 [TBL] [Abstract][Full Text] [Related]
38. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome. Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606 [TBL] [Abstract][Full Text] [Related]
39. Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology. Cohen SA; Pritchard CC; Jarvik GP Annu Rev Genomics Hum Genet; 2019 Aug; 20():293-307. PubMed ID: 30848956 [TBL] [Abstract][Full Text] [Related]